Injectable Drug
- All
- News
- Videos
-
Novo Nordisk's CagriSema Delivers 23% Weight Loss In Trial But Still Trails Eli Lilly's Tirzepatide
CagriSema is a once-weekly subcutaneous injection, which is being investigated by Novo Nordisk as a treatment for adults with overweight or obesity.
-
10 Common Side Effects Of Mounjaro, Ozempic And How To Handle Them, As Per An Apollo Doctor
From dry mouth and fatigue to nausea and weight regain, an expert breaks down 10 common side effects of weight-loss drugs and how to deal with them
-
Aishwarya Mohanraj Says She Used Mounjaro For 22 Kg Weight Loss: Doctor Explains How It Works And Who Should Avoid It
Mounjaro, a diabetes and weight-loss drug, is the brand name for tirzepatide. It is a prescription drug primarily used for type-2 diabetes. The drug is also widely used for its weight loss benefits.
-
Novo Nordisk Sues Telehealth Company Over 'Knock-Off' Weight Loss Drugs, Flags Patient Safety Risks
The lawsuit, filed in the US, alleges that Hims infringed Novo Nordisk's patent by mass marketing compounded semaglutide products that have not been cleared by the US Food and Drug Administration (FDA).
-
What Is 'Penisgate' At Winter Olympics? Ski Jumpers Accused Of Injecting Their Genitalia With Drugs
WADA is looking into allegations that ski jumpers inject paraffin or hyaluronic acid to enlarge their penises, which affects suit size and jump performance.
-
UK Woman Left In Diabetic Coma After Using Fake Ozempic Bought On Facebook
A UK woman narrowly survived after using a counterfeit Ozempic pen bought on Facebook, prompting warnings over fake weight loss drugs and online scams.
-
Breast Cancer Drug Delivery Gets Precise Through Nano Injection Platform Developed By IIT Madras
An international team of researchers led by the Indian Institute of Technology (IIT) Madras has developed a cutting-edge nanoinjection drug delivery platform that has the potential to make breast cancer treatment safer.
-
Ozempic Enters India: Diabetes Drug, Not A Miracle Fix, Novo Nordisk MD To NDTV
In an exclusive interaction with NDTV, Managing Director of Novo Nordisk India, Vikrant Shrotriya, said the launch of injectable semaglutide marks a significant moment for diabetes treatment.
-
Ozempic Too Costly? 7 Cheaper And Clinically Approved Alternatives Available In India
Ozempic has hit the Indian market and will be available at Rs 2,200 per week. But did you know that there are alternatives which can also aid in weight loss?
-
Can Non-Diabetics Take Ozempic For Weight Loss? Doctor Answers
Ozempic is the brand name for a medication called semaglutide, which is primarily used to manage type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists
-
Novo Nordisk's CagriSema Delivers 23% Weight Loss In Trial But Still Trails Eli Lilly's Tirzepatide
CagriSema is a once-weekly subcutaneous injection, which is being investigated by Novo Nordisk as a treatment for adults with overweight or obesity.
-
10 Common Side Effects Of Mounjaro, Ozempic And How To Handle Them, As Per An Apollo Doctor
From dry mouth and fatigue to nausea and weight regain, an expert breaks down 10 common side effects of weight-loss drugs and how to deal with them
-
Aishwarya Mohanraj Says She Used Mounjaro For 22 Kg Weight Loss: Doctor Explains How It Works And Who Should Avoid It
Mounjaro, a diabetes and weight-loss drug, is the brand name for tirzepatide. It is a prescription drug primarily used for type-2 diabetes. The drug is also widely used for its weight loss benefits.
-
Novo Nordisk Sues Telehealth Company Over 'Knock-Off' Weight Loss Drugs, Flags Patient Safety Risks
The lawsuit, filed in the US, alleges that Hims infringed Novo Nordisk's patent by mass marketing compounded semaglutide products that have not been cleared by the US Food and Drug Administration (FDA).
-
What Is 'Penisgate' At Winter Olympics? Ski Jumpers Accused Of Injecting Their Genitalia With Drugs
WADA is looking into allegations that ski jumpers inject paraffin or hyaluronic acid to enlarge their penises, which affects suit size and jump performance.
-
UK Woman Left In Diabetic Coma After Using Fake Ozempic Bought On Facebook
A UK woman narrowly survived after using a counterfeit Ozempic pen bought on Facebook, prompting warnings over fake weight loss drugs and online scams.
-
Breast Cancer Drug Delivery Gets Precise Through Nano Injection Platform Developed By IIT Madras
An international team of researchers led by the Indian Institute of Technology (IIT) Madras has developed a cutting-edge nanoinjection drug delivery platform that has the potential to make breast cancer treatment safer.
-
Ozempic Enters India: Diabetes Drug, Not A Miracle Fix, Novo Nordisk MD To NDTV
In an exclusive interaction with NDTV, Managing Director of Novo Nordisk India, Vikrant Shrotriya, said the launch of injectable semaglutide marks a significant moment for diabetes treatment.
-
Ozempic Too Costly? 7 Cheaper And Clinically Approved Alternatives Available In India
Ozempic has hit the Indian market and will be available at Rs 2,200 per week. But did you know that there are alternatives which can also aid in weight loss?
-
Can Non-Diabetics Take Ozempic For Weight Loss? Doctor Answers
Ozempic is the brand name for a medication called semaglutide, which is primarily used to manage type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists
